Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Chi-Tung Cheng

Identification of SPHK1 as a Therapeutic Target and Marker of Poor Prognosis in Cholangiocarcinoma

Oncotarget
Oncology
2015English

The Prognosis of Blunt Bowel and Mesenteric Injury—the Pitfall in the Contemporary Image Survey

Journal of Clinical Medicine
2019English

Related publications

Pyruvate Kinase M2 Is a Poor Prognostic Marker of and a Therapeutic Target in Ovarian Cancer

PLoS ONE
Multidisciplinary
2017English

RETRACTED: Proteomics-Based Identification of Α-Enolase as a Potential Prognostic Marker in Cholangiocarcinoma

Clinical Biochemistry
MedicineClinical Biochemistry
2012English

Clinical Importance of S100A9 in Osteosarcoma Development and as a Diagnostic Marker and Therapeutic Target

Bioengineered
Applied MicrobiologyBiotechnologyMedicineBioengineering
2019English

Correction: Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer

PLoS ONE
Multidisciplinary
2015English

Correction: Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer

PLoS ONE
Multidisciplinary
2020English

623 CRD-BP as a Potential Prognostic Marker and Therapeutic Target in Melanoma

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2016English

Identification of Glycogen Synthase Kinase 3α as a Therapeutic Target in Melanoma

Pigment Cell and Melanoma Research
BiochemistryDermatologyOncologyGeneticsMolecular Biology
2013English

Genomic Analysis Reveals RhoC as a Potential Marker in Hepatocellular Carcinoma With Poor Prognosis

British Journal of Cancer
Cancer ResearchOncology
2004English

SPHK1 Is a Novel Target of Metformin in Ovarian Cancer

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy